Caprock Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $1.33M | Buy |
5,919
+279
| +5% | +$62.5K | 0.04% | 380 |
|
2024
Q4 | $1.29M | Sell |
5,640
-92
| -2% | -$21K | 0.04% | 360 |
|
2024
Q3 | $1.4M | Buy |
5,732
+2,806
| +96% | +$685K | 0.05% | 314 |
|
2024
Q2 | $560K | Buy |
2,926
+1,223
| +72% | +$234K | 0.02% | 509 |
|
2024
Q1 | $337K | Buy |
1,703
+90
| +6% | +$17.8K | 0.02% | 520 |
|
2023
Q4 | $277K | Sell |
1,613
-378
| -19% | -$65K | 0.02% | 558 |
|
2023
Q3 | $294K | Buy |
1,991
+141
| +8% | +$20.9K | 0.02% | 497 |
|
2023
Q2 | $404K | Sell |
1,850
-9
| -0.5% | -$1.97K | 0.03% | 422 |
|
2023
Q1 | $407K | Buy |
1,859
+690
| +59% | +$151K | 0.03% | 410 |
|
2022
Q4 | $243K | Sell |
1,169
-30
| -3% | -$6.24K | 0.02% | 457 |
|
2022
Q3 | $262K | Buy |
1,199
+99
| +9% | +$21.6K | 0.03% | 444 |
|
2022
Q2 | $231K | Buy |
1,100
+118
| +12% | +$24.8K | 0.02% | 461 |
|
2022
Q1 | $238K | Buy |
982
+49
| +5% | +$11.9K | 0.02% | 506 |
|
2021
Q4 | $243K | Buy |
+933
| New | +$243K | 0.02% | 497 |
|
2021
Q1 | – | Sell |
-1,039
| Closed | -$221K | – | 522 |
|
2020
Q4 | $221K | Buy |
+1,039
| New | +$221K | 0.03% | 422 |
|